Corebridge Financial Inc. Sells 5,754 Shares of Maximus, Inc. (NYSE:MMS)

Corebridge Financial Inc. cut its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 97,579 shares of the health services provider's stock after selling 5,754 shares during the period. Corebridge Financial Inc. owned 0.17% of Maximus worth $7,284,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of MMS. Vanguard Group Inc. increased its position in shares of Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after buying an additional 205,564 shares during the period. Bridge City Capital LLC increased its holdings in Maximus by 0.9% during the 4th quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock worth $2,128,000 after acquiring an additional 254 shares during the period. KLP Kapitalforvaltning AS purchased a new stake in Maximus in the 4th quarter worth approximately $1,821,000. AXQ Capital LP bought a new position in Maximus in the 4th quarter valued at $206,000. Finally, Hillsdale Investment Management Inc. grew its position in shares of Maximus by 0.4% during the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock valued at $3,912,000 after purchasing an additional 230 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Price Performance

MMS stock traded up $1.73 during mid-day trading on Wednesday, hitting $70.41. 112,687 shares of the stock were exchanged, compared to its average volume of 685,350. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market capitalization of $3.99 billion, a price-to-earnings ratio of 15.15 and a beta of 0.71. The business has a fifty day moving average price of $69.57 and a 200 day moving average price of $77.51. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.70%. The ex-dividend date was Friday, February 14th. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MMS. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Insider Activity at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.